Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Long non-coding RNA PMS1 homolog 2 mismatch repair system component pseudogene 2 (
PMS2L2
) is a key player in
lipopolysaccharide
-induced inflammatory responses. Preliminary deep sequencing data revealed that
PMS2L2
was downregulated in gastric adenocarcinoma (GA) tissues compared with healthy adjacent tissues and the aim of the present study was to investigate the role of
PMS2L2
in GA. In the present study, reverse transcription-quantitative PCR assays were performed to analyze gene expression. Cell transfections were performed to analyze gene interactions and Transwell assays were performed to analyze cell invasion and migration. The results revealed that
PMS2L2
expression was downregulated in cancer tissues obtained from patients with GA compared with healthy adjacent tissues and was not significantly affected by clinical stage. Furthermore, low levels of
PMS2L2
in cancer tissues were closely associated with a low overall 5-year survival rate in patients. MicroRNA (miR)-25 was upregulated in GA tissues compared with healthy adjacent tissues and inversely associated with
PMS2L2
levels. In GA cells
in vitro
, overexpression of
PMS2L2
downregulated the expression of miR-25, while miR-25 overexpression did not significantly affect
PMS2L2
expression. Furthermore,
PMS2L2
overexpression inhibited the migration and invasion of GA cells. miR-25 overexpression partially rescued the decreased migration and invasion of GA cells caused by
PMS2L2
overexpression. Therefore,
PMS2L2
may downregulate miR-25 expression to inhibit GA.
...
PMID:Downregulation of lncRNA PMS2L2 in patients with gastric adenocarcinoma predicts poor prognosis. 3256 74